课题基金 / 基金详情

COVID-19 Variant Supplement - Rapid bench-to-human development of safe and effective aerosol vaccine strategies against Covid-19

COVID-19 Variant Supplement - Rapid bench-to-human development of safe and effective aerosol vaccine strategies against Covid-19
COVID-19 变体补充剂 - 针对 Covid-19 的安全有效的气溶胶疫苗策略的快速人体试验开发
批准号:
442864
负责人:
Xing Zhou
金额:
$3.64万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2021
资助国家:
加拿大
项目状态:
已结题
起止时间:
2021-02-01 至 2022-02-01

项目摘要

项目成果

Xing Zhou的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The pandemic of Covid-19 caused by respiratory SARS-CoV-2 infection has brought the world to a standstill. The physical-distancing strategy currently implemented in the pandemic aims to prevent the majority of Canadians from being infected by SARS-CoV-2.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rapid bench-to-human development of safe and effective aerosol vaccine strategies against Covid-19
  • 批准号:
    430637
  • 项目类别:
    Operating Grants
  • 资助金额:
    $139.94万
  • 财政年份:
    2020
  • 负责人:
    Xing Zhou
  • 依托单位:
Respiratory mucosal immunity and novel vaccination strategies against pulmonary tuberculosis
  • 批准号:
    353762
  • 项目类别:
    Operating Grants
  • 资助金额:
    $179.41万
  • 财政年份:
    2016
  • 负责人:
    Xing Zhou
  • 依托单位:
Novel multivalent chimpanzee adenovirus-based vaccines against pulmonary tuberculosis
  • 批准号:
    343353
  • 项目类别:
    Operating Grants
  • 资助金额:
    $63.77万
  • 财政年份:
    2016
  • 负责人:
    Xing Zhou
  • 依托单位:
Unraveling the immune mechanisms of delayed onset of T cell immunity against pulmonary tuberculosis
  • 批准号:
    266062
  • 项目类别:
    Operating Grants
  • 资助金额:
    $51.79万
  • 财政年份:
    2012
  • 负责人:
    Xing Zhou
  • 依托单位:
海外基金